Edition:
United Kingdom

Shin Nippon Biomedical Laboratories Ltd (2395.T)

2395.T on Tokyo Stock Exchange

576JPY
22 Nov 2017
Change (% chg)

¥-7 (-1.20%)
Prev Close
¥583
Open
¥589
Day's High
¥589
Day's Low
¥576
Volume
104,500
Avg. Vol
264,197
52-wk High
¥742
52-wk Low
¥491

Latest Key Developments (Source: Significant Developments)

Shin Nippon Biomedical Laboratories announces exercise of options
Thursday, 9 Jun 2016 

Shin Nippon Biomedical Laboratories Ltd <2395.T>: Says 8,500 units of its 2nd series options were exercised to 850,000 shares of its common stock on June 8 and June 9 .Says the shares were exercised at the price of 658 yen per share.  Full Article

Shin Nippon Biomedical Laboratories announces exercise of warrants
Tuesday, 7 Jun 2016 

Shin Nippon Biomedical Laboratories Ltd <2395.T> : Says 9,735 of its second series warrants were exercised into 973,500 shares, during the period from June 1 to June 7 .The shares exercised for about 6.5 million yen in total.  Full Article

SHIN NIPPON BIOMEDICAL LABORATORIES to set up JV in China with Shanghai Shimao
Wednesday, 18 May 2016 

SHIN NIPPON BIOMEDICAL LABORATORIES LTD <2395.T> : Says it plans to set up a joint venture in China with Shanghai Shimao Co Ltd <600823.SS> in June, with registered capital of 5 million yuan . Says JV to be mainly engaged in medical tourism and medical consulting in Japan which is targeted to the China's wealthy class .Says SHIN NIPPON BIOMEDICAL LABORATORIES and Shanghai Shimao to hold a 40 percent stake and a 60 percent stake in JV respectively.  Full Article

SHIN NIPPON BIOMEDICAL LABORATORIES to set up unit in US
Tuesday, 17 May 2016 

SHIN NIPPON BIOMEDICAL LABORATORIES LTD <2395.T> :Says it plans to set up a development company in US named as Satsuma Pharmaceuticals, Inc, for TR business expansion.  Full Article

Shin Nippon Biomedical Laboratories announces business alliance with Japan-based company
Tuesday, 5 Apr 2016 

Shin Nippon Biomedical Laboratories Ltd:Formed a business alliance with a Japan-based company (RGS).Says two entities will cooperate on regenerative medicine field.Says invested 5 mln yen in RGS on March 31 and holds 14.5 pct voting rights in it.  Full Article